Long-term management of patients with metastatic renal cell carcinoma on targeted agents
出版年份 2010 全文链接
标题
Long-term management of patients with metastatic renal cell carcinoma on targeted agents
作者
关键词
-
出版物
Expert Review of Anticancer Therapy
Volume 10, Issue 12, Pages 1883-1889
出版商
Informa UK Limited
发表日期
2010-11-27
DOI
10.1586/era.10.195
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Complete remission with TKI in renal cell carcinomas: Experience in 65 patients of the French Kidney Cancer Group.
- (2017) L. Albiges et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials
- (2010) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell Carcinoma
- (2010) C. Lance Cowey et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
- (2009) G. Di Lorenzo et al. ANNALS OF ONCOLOGY
- Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinoma
- (2009) Danai D. Daliani et al. BJU INTERNATIONAL
- Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis
- (2009) Brett E. Houk et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cutaneous Squamous Cell Carcinoma and Inflammation of Actinic Keratoses Associated with Sorafenib
- (2009) Zita Dubauskas et al. Clinical Genitourinary Cancer
- Keratoacanthomas and Squamous Cell Carcinomas in Patients Receiving Sorafenib
- (2009) Jean Philippe Arnault et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma
- (2009) Eric Jonasch et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials
- (2009) Youjin Je et al. LANCET ONCOLOGY
- Adverse effects of anticancer agents that target the VEGF pathway
- (2009) Helen X. Chen et al. Nature Reviews Clinical Oncology
- Hand-Foot Syndrome (Hand-Foot Skin Reaction, Palmar-Plantar Erythrodysesthesia): Focus on Sorafenib and Sunitinib
- (2009) Adam D. Lipworth et al. ONCOLOGY
- Management of sorafenib, sunitinib, and temsirolimus toxicity in metastatic renal cell carcinoma
- (2009) Catherine Guevremont et al. Current Opinion in Supportive and Palliative Care
- Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features
- (2008) J. Bellmunt et al. ANNALS OF ONCOLOGY
- Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm
- (2008) Brian Shuch et al. BJU INTERNATIONAL
- Heart failure associated with sunitinib malate
- (2008) Aarif Y. Khakoo et al. CANCER
- Sunitinib for Treatment of Advanced Renal Cell Cancer: Primary Tumor Response
- (2008) A. A.M. van der Veldt et al. CLINICAL CANCER RESEARCH
- Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206
- (2008) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Surgical Morbidity Associated With Administration of Targeted Molecular Therapies Before Cytoreductive Nephrectomy or Resection of Locally Recurrent Renal Cell Carcinoma
- (2008) Vitaly Margulis et al. JOURNAL OF UROLOGY
- Radical Nephrectomy for pT1a Renal Masses May be Associated With Decreased Overall Survival Compared With Partial Nephrectomy
- (2008) R. Houston Thompson et al. JOURNAL OF UROLOGY
- Response of the Primary Tumor to Neoadjuvant Sunitinib in Patients With Advanced Renal Cell Carcinoma
- (2008) Anil A. Thomas et al. JOURNAL OF UROLOGY
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib
- (2007) I. Tamaskar et al. ANNALS OF ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started